CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES:
Net (loss) income	$ (5,183)	$ (14,056)	$ 3,406
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation	26,749	26,720	27,823
Amortization, including accretion and write-off of deferred financing costs	8,132	8,055	6,648
Deferred income taxes	(4,038)	(5,110)	(511)
Loss (earnings) of equity method investee	522	823	(3,658)
Gain on sale of fixed assets	(860)	(241)	(165)
Share-based compensation expense	3,322	5,942	5,960
Excess tax deficiency (benefit) related to share-based compensation expense	230	543	(563)
Gain on sale of Canton Facility, net	0	0	(30,718)
Gain on disposal of business and joint venture, net	0	0	(2,942)
Change in fair value of earn-out contingent consideration	0	0	2,065
Changes in operating assets and liabilities:
Accounts receivable, net	(5,854)	(13,161)	(17,019)
Inventories, net	(31,563)	(20,127)	(51,270)
Prepaid expenses and other assets	16,625	(5,159)	(5,116)
Accounts payable	1,090	18,489	16,515
Accrued expenses and other liabilities	(4,226)	4,088	13,297
Net cash provided by (used for) operating activities	4,946	6,806	(36,248)
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(38,498)	(31,609)	(27,031)
Proceeds from sale of fixed assets	1,869	158	268
Proceeds from settlement of net investment hedges	0	3,820	0
Proceeds from disposal of business, net	0	0	1,837
Proceeds from disposal of joint venture, net	0	0	20,999
Proceeds from sale of Canton Facility, net	0	0	35,167
Investment in venture capital fund, net	(350)	(950)	(3,199)
Net cash (used for) provided by investing activities	(36,979)	(28,581)	28,041
FINANCING ACTIVITIES:
Revolving credit facility borrowings	117,369	21,562	91,913
Revolving credit facility payments	(96,568)	(18,000)	(64,000)
Proceeds from issuance of debt	35,757	38,940	45,753
Repayments of debt	(35,102)	(42,248)	(48,107)
Earn-out consideration cash payment	0	(6,276)	0
Other financing costs	(2,251)	(484)	(18)
Repurchase of Common Shares to satisfy employee tax withholding	(1,720)	(791)	(2,665)
Net cash provided by (used for) financing activities	17,485	(7,297)	22,876
Effect of exchange rate changes on cash and cash equivalents	591	(1,677)	(3,041)
Net change in cash and cash equivalents	(13,957)	(30,749)	11,628
Cash and cash equivalents at beginning of period	54,798	85,547	73,919
Cash and cash equivalents at end of period	40,841	54,798	85,547
Supplemental disclosure of cash flow information:
Cash paid for interest	13,007	7,293	6,055
Cash paid for income taxes, net	$ 10,302	$ 6,178	$ 11,267

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.